8 results match your criteria: "University Hospital Complex the "Bon Samaritain"[Affiliation]"
BMC Infect Dis
November 2024
Faculty of Human Health Sciences, N'Djamena University, N'Djamena, Chad.
Background: Chad with 7,698 confirmed cases of infection and 194 deaths since the beginning of the COVID-19 pandemic, is one of the African countries with the lowest reported case numbers. However, this figure likely underestimates the true spread of the virus due to the low rate of diagnosis. The high rate of asymptomatic infections reflects the reality of SARS-CoV-2 transmission in Chad.
View Article and Find Full Text PDFVirus Res
December 2024
Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), INSERM U1058, University of Montpellier, French Blood Establishment (EFS), Montpellier, France. Electronic address:
Zika virus (ZIKV) is a major public health problem worldwide. After several reported outbreaks, the current extent of infections caused by this orthoflavivirus in the Sahel remains to be explored. We investigated the prevalence of neutralizing antibodies against ZIKV in the general population, in HIV-infected individuals and in livestock in Chad using a seroneutralization assay that ensures high specificity level.
View Article and Find Full Text PDFImmun Inflamm Dis
January 2024
Laboratoire des Grandes Epidémies Tropicales (LAGET), Complexe Hospitalo-Universitaire le Bon Samaritain, N'Djamena, Chad.
Introduction: Neutralizing antibodies (NAbs) are an important specific defence against viral infections, as these antibodies bind to specific receptor(s) and block the viral entry. NAbs assessments are therefore useful in determining individual or herd immunity to SARS-CoV-2. This study aims to deepen the investigation by assessing the positivity rate of neutralizing anti-spike antibodies to understand the real protection of the studied population against SARS-CoV-2.
View Article and Find Full Text PDFFront Public Health
January 2023
Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), INSERM U1058, University of Montpellier, French Blood Establishment (EFS), University of Antilles, Montpellier, France.
Vaccination against the COVID-19 virus is currently the best option to combat the SARS-CoV-2 pandemic worldwide. However, in addition to logistical and economic barriers, hesitancy to be vaccinated threatens to jeopardize efforts to contain the disease. An increasing number of people in Africa are delaying or rejecting recommended vaccines.
View Article and Find Full Text PDFJ Public Health Afr
May 2022
Pontificia Universidad Católica de Chile, Santiago, Chile.
COVID-19 is affecting different countries and populations unequally. In this sense, sub-Saharan countries represent a particularly vulnerable context due to their unique demographic and health circumstances. A holistic approach to Covid-19 is urged, one that considers the social-cultural contexts of people's lives.
View Article and Find Full Text PDFJ Trop Med
April 2022
Dhaka Medical College, Secretariat Road, Central Shaeed Minar Area, Shahbagh, Dhaka, Bangladesh.
Introduction: Malaria is an endemic disease in sub-Saharan Africa. In clinical practice, the main concern is the overdiagnosis of malaria leading to inappropriate drug prescription without laboratory confirmation.
Objective: This study aimed to evaluate clinical examination reliability compared with translational laboratory methods of malaria diagnosis.
J Community Health
April 2021
Centre for Biomedical Law and Ethics, KU Leuven, Kapucijnenvoer 35/3, 3000, Leuven, Belgium.
Virol Sin
December 2020
University Hospital Complex the "Bon Samaritain", N'Djamena, BP 456, Republic of Chad.